New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment
SAN ANTONIO, Dec. 15 /PRNewswire/ -- Denosumab is a new drug being studied to prevent fractures in breast cancer patients receiving hormonal therapy. Results of a phase 3 clinical trial using denosumab were presented Friday evening at the San Antonio Breast Cancer Symposium by Georgiana Ellis, MD, from the Seattle Cancer Care Alliance.
full article: http://sev.prnewswire.com/biotechnol...5122007-1.html |
Sign me up! BB
|
me too!!! wonder why no one I see for my treatment (at another facility in Seattle) has heard of this?????
|
All times are GMT -7. The time now is 04:05 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021